Meningitis-associated Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 317

Kim, K.J., Elliott, S.A., DiCello, F., Stins, M.F., Kim, K.S., 2003. The K1 capsule modulates traf-
icking of E. coli -containing vacuoles and enhances intracellular bacterial survival in human
brain microvascular endothelial cells. Cell Microbiol. 5, 245-252 .
Kim, K.S., 1985. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin and
ampicillin-chloramphenicol in the treatment of experimental E.coli bacteremia and meningitis.
Antimicrobial. Agents Chemother. 28, 433-436 .
Kim, K.S., 2001. E. coli translocation at the blood-brain barrier. Infect. Immun. 69, 5217-5222 .
Kim, K.S., 2002. Strategy of E. coli for crossing the blood-brain barrier. J. Infect. Dis. 186,
S220-S224 .
Kim, K.S., 2003. Neurological diseases: pathogenesis of bacterial meningitis: from bacteremia to
neuronal injury. Nat. Rev. Neurosci. 4, 376-385 .
Kim, K.S., 2008. Mechanisms of microbial traversal of the blood-brain barrier. Nat. Rev. Microbiol.
6, 625-634 .
Kim, K.S., 2010. Acute bacterial meningitis in infants and children. Lancet. Infect. Dis. 10, 32-42 .
Kim, K.S., 2012. Current concepts on the pathogenesis of E. coli meningitis; implications for pre-
vention and therapy. Curr. Opin. Infect. Dis. 25, 273-278 .
Kim, K.S., Itabashi, H., Gemski, P., Sadoff, J., Warren, R.L., Cross, A.S., 1992. The K1 capsule is
the critical determinant in the development of Escherichia coli meningitis in the rat. J. Clin.
Invest. 90, 897-905 .
Kim, K.S., Kang, J.H., Cross, A.S., 1986. The role of capsular antigens in serum resistance and
in vivo virulence of Escherichia coli . FEMS Microbiol. Lett. 35, 275-278 .
Kim, K.S., Kang, J.H., Cross, A.S., Kaufman, B., Zollinger, W., Sadoff, J., 1988. Functional activi-
ties of monoclonal antibodies to O-side chain of Escherichia coli lipopolysaccharides in vitro
and in vivo. J. Infect. Dis. 157, 47-53 .
Kim, K.S., Wass, C.A., Cross, A.S., 1997. Blood-brain barrier permeability during the development
of experimental bacterial meningitis in the rat. Exp. Neurol. 145, 253-257 .
Kim, Y., Pearce, D., Kim, K.S., 2008. Ca2+/Calmodulin-dependent invasion of the human brain
microvascular endothelial cells by Escherichia coli K1. Cell Tissue Res. 332, 427-433 .
Kim, Y.V., DiCello, F., Hillaire, C.S., Kim, K.S., 2004. Protease-activated receptors of human brain
microvascular endothelial cells: expression and differential Ca 2+ signaling induced by throm-
bin and protease-activated receptor-1 activating peptide. Am. J. Physiol. Cell Physiol. 286,
C31-C42 .
Klinger, G., Chin, C.-N., Beyene, J., Perlman, M., 2000. Predicting the outcome of neonatal bacte-
rial meningitis. Pediatrics 106, 477-482 .
Knodler, L.A., Celli, J., Finlay, B.B., 2001. Pathogenic trickery: deception of host cell processes.
Nat. Rev. Mol. Cell Biol. 2, 578-588 .
Korczak, B., Frey, J., Schrenzel, J., et al., 2005. Use of diagnostic microarrays for determination of
virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis. J. Clin.
Microbiol. 43, 1024-1031 .
Korhonen, T.K., Valtonen, M.V., Parkkinen, J., et al., 1985. Serotypes, hemolysin production, and
receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis.
Infect. Immun. 48, 486-491 .
Liu, S., Li, L., Luo, Z., et al., 2011. Superior effect of hypertonic saline over mannitol to attenuate
cerebral edema in a rabbit bacterial meningitis model. Crit. Care. Med. 39, 1467-1473 .
Lu, S., Zhang, X., Zhu, Y., Kim, K., Yang, J., JIN, Q., 2011. Complete genome sequence of the
neonatal meningitis-associated Escherichia coli strain CE10. J. Bacteriol. 193, 7005 .
Ludwig, G.V., Kondig, J.P., Smith, J.F., 1996. A putative receptor for Venezuelan equine encephali-
tis virus from mosquito cells. J. Virol. 70, 5592-5599 .